EVALUATION OF PHENOLIC COMPOUNDS IN WHITE WINES TREATED WITH ENZYMES by Elena Cristina SCUTARAȘU, Valeriu V. COTEA, Camelia Elena LUCHIAN, Lucia Carmen TRINCĂ, Andrei SCUTARAȘU

Get full text

Carbaryl Sorption by Porogen-Treated Banana Pith Carbon by M. Sathishkumar, J.G. Choi, C.S. Ku, K. Vijayaraghavan, A.R. Binupriya, S.E. Yun

Get full text

Neuroglobin: A promising candidate to treat neurological diseases by Ivan Millan Yañez, Isabel Torres-Cuevas, Marisol Corral-Debrinski

“…This review surveys up-to-date knowledge and emphasizes on existing investigations regarding neuroglobin physiological functions, which remain since its discovery in 2000 under intense debate and the possibility of using neuroglobin either by gene therapy or its direct delivery into the brain to treat neurological disorders.…”
Get full text

Evaluation of ovarian functions in girls treated for hematological malignancy by Şule Çalışkan Kamış, Begül Yağcı, Ayşe Selcan Koç, Metin Çil

Get full text

Physicochemical Properties of Rice Flour Suspension Treated by Ultrahigh Hydrostatic Pressure by Ji Won Park, Jeong Hyun Seo, Chae Young Hong, Min Young Kim, Yoon Jeong Lee, A.-Reum Chun, Youn Ri Lee, Junsoo Lee, Heon Sang Jeong

Get full text

Clinical efficacy of secukinumab in treating sleep disorders in psoriatic patients by ZHOU Cuimei, LIU Min, LIU Chang, REN Yuqian, MENG Jichao, YU Yaxin, LIN Xiaoru

“…[Objective] To evaluate the efficacy and safety of secukinumab in treating psoriatic patients with sleep disorders, and its impact on sleep quality. …”
Get full text

Comparison of Chemically Treated, Pasteurized, and Microwave-Treated (at Different Time Durations) Chia Seeds Added To Mango-Whey Beverage, during Different Storage Periods, for Ph... by Farzana Siddique, Ashiq Hussain, Amer Ali Mahdi, Mansoor Hassan, Saima Noreen, Tahira Siddique, Syeda Ayesha Batool, Shazia Yaqub, Faiza Iftikhar Gorsi, Samina Kauser, Haya Fatima, Sameh A. Korma

“…The total plate count of the beverage was the highest (2.36 ± 0.1 CFU/ml) for control, followed by chemically treated (2.17 ± 0.1 CFU/ml) and lowest in microwave-treated (0.98 ± 0.1 CFU/ml) at the start of the experiment, and this total plate count was found to be increasing in all treatments during storage. …”
Get full text

New options for treating acute pain after laparoscopic cholecystectomy by O.V. Pylypenko, O.V. Kravets

Get full text

Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases by Sixiu Deng, Huangfan Xie, Bingqing Xie

Get full text

Treating non-motor symptoms in dystonia: a systematic review by Dana Sugar, Sarah Pirio Richardson

“…Dystonia also encompasses non-motor symptoms which are becoming increasingly recognized as important contributors to quality of life. Less attention has been paid to treating these non-motor symptoms. …”
Get full text

Modern possibilities for treating acute rhinosinusitis using herbal medications by Valery M. Svistushkin, Liliya V. Selezneva, Mikhail V. Svistushkin, Gaya V. Lebedeva, Igor A. Zinchenko

Get full text

Evaluation of Interfering RNA Efficacy in Treating Hepatitis B: Is It Promising? by Giovana Paula Angelice, Pedro Henrique Roque, Gabriel Valente, Krishna Galvão, Livia Melo Villar, Vinicius Motta Mello, Francisco C. A. Mello, Bárbara Vieira Lago

“…Nowadays, several drugs are used to treat chronic hepatitis B; however, full healing remains controversial. …”
Get full text

Demographics, Disease Characteristics, and Time to Effective Treatment of Patients with Psoriasis in the Ghent PsoPlus Cohort of 2021 by Evelyn Meulewaeter, Anke Eylenbosch, Evelien Verhaeghe, Rani Soenen, Jo Lambert

“…It also examined whether a treat-to-target (T2T) approach, which is implemented in PsoPlus, has an impact on treatment choice and disease progression. …”
Get full text

TREAT-TO-TARGET SLE RECOMMENDATIONS FROM THE INTERNATIONAL TASK FORCE AND RUSSIAN EXPERTS’ COMMENTARIES by S. K. Soloviev, E. A. Aseeva, T. V. Popkova, N. G. Klyukvina, T. M. Reshetnyak, T. A. Lisitsyna, N. M. Kosheleva, M. E. Tsanyan, A. A. Mesnyankina, T. A. Panafidina, L. V. Kondratyeva, N. V. Seredavkina, E. V. Gerasimova

“…The treatment strategy for RDs was also changed. The treat-to-target concept was put forth for rheumatoid arthritis in 2010 and for ankylosing spondylitis later. …”
Get full text

Real-world clinical and psychosocial outcomes among people with mild or moderate haemophilia A treated on-demand in the Italian CHESS II cohort: a real-world data analysis by Castaman Giancarlo, Mancuso Maria Elisa, Di Minno Matteo Nicola Dario, Sannino Luigi, Tempre Rosaria, Bendinelli Sara, Blenkiron Tom, Burke Tom, Grazzi Enrico Ferri

Get full text

A Case of Hyperimmunoglobulinemia D Syndrome Successfully Treated with Canakinumab by Elena Tsitsami, Charis Papadopoulou, Matthaios Speletas

“…Treatment with canakinumab in a final single dose of 4 mg/kg every 4 weeks resulted in the disappearance of febrile attacks and a considerable improvement of patients’ quality of life during a 12-month follow-up period. …”
Get full text

Residual Renal Function in Children Treated with Chronic Peritoneal Dialysis by Maria Roszkowska-Blaim, Piotr Skrzypczyk

“…Preserved RRF improves survival and quality of life in adult ESRD patients treated with peritoneal dialysis. …”
Get full text

Cutaneous IgG4-related disease treated with dupilumab by Mafalda Pestana, Alexandre João, Susana Palma-Carlos, Paula Leiria-Pinto, Ana L. João

“…Dermatologic examination revealed widespread erythematous-brownish papules and nodules, prompting a skin biopsy that showed dense infiltration by immunoglobulin G4 (IgG4)-positive plasma cells, leading to a diagnosis of IgG4-related disease (IgG4-RD). The patient was treated with dupilumab, resulting in complete skin lesion resolution and significant improvement in quality of life. …”
Get full text

Three locally invasive infantile fibrosarcoma cases treated with larotrectinib by Hikmet Gülşah Tanyıldız, Yasin Yılmaz, Doğa Dalay, Şifa Şahin, Serap Karaman, Ayşegül Ünüvar, Zeynep Karakaş, Deniz Tuğcu

Get full text

Prognostic factors associated with achieving minimal disease activity in early psoriatic arthritis patients treated according to “treat-to-target” st rategy within 12 months by E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, S. I. Glukhova

“…Background. The goal of “treat-to-target” strategy (T2T) in psoriatic arthritis (PsA) is attaining remission or minimal disease activity (MDA). …”
Get full text